LifeTech Scientific Corporation
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more
LifeTech Scientific Corporation (LFTSF) - Total Liabilities
Latest total liabilities as of June 2025: $1.60 Billion USD
Based on the latest financial reports, LifeTech Scientific Corporation (LFTSF) has total liabilities worth $1.60 Billion USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
LifeTech Scientific Corporation - Total Liabilities Trend (2010–2024)
This chart illustrates how LifeTech Scientific Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
LifeTech Scientific Corporation Competitors by Total Liabilities
The table below lists competitors of LifeTech Scientific Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mani, Inc.
PINK:MNICF
|
USA | $4.43 Billion |
|
Protector Forsikring ASA
OTCGREY:PSKRF
|
USA | $23.39 Billion |
|
Guangdong Tapai Group Co Ltd
SHE:002233
|
China | CN¥1.19 Billion |
|
Jiangsu Shentong Valve Co Ltd
SHE:002438
|
China | CN¥2.36 Billion |
|
Xiamen Meiya Pico Information
SHE:300188
|
China | CN¥1.79 Billion |
|
Burke & Herbert Financial Services Corp. Common Stock
NASDAQ:BHRB
|
USA | $7.07 Billion |
|
BrightView Holdings
NYSE:BV
|
USA | $1.55 Billion |
|
Aguas Andinas S.A
SN:AGUAS-A
|
Chile | CL$1.82 Trillion |
Liability Composition Analysis (2010–2024)
This chart breaks down LifeTech Scientific Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LifeTech Scientific Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LifeTech Scientific Corporation (2010–2024)
The table below shows the annual total liabilities of LifeTech Scientific Corporation from 2010 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.42 Billion | +3.83% |
| 2023-12-31 | $1.37 Billion | +78.45% |
| 2022-12-31 | $769.05 Million | +17.66% |
| 2021-12-31 | $653.61 Million | +9.66% |
| 2020-12-31 | $596.06 Million | -2.38% |
| 2019-12-31 | $610.56 Million | +112.56% |
| 2018-12-31 | $287.24 Million | +34.36% |
| 2017-12-31 | $213.79 Million | -53.47% |
| 2016-12-31 | $459.47 Million | -26.08% |
| 2015-12-31 | $621.61 Million | +51.62% |
| 2014-12-31 | $409.99 Million | +44.40% |
| 2013-12-31 | $283.93 Million | +348.29% |
| 2012-12-31 | $63.34 Million | +39.57% |
| 2011-12-31 | $45.38 Million | -70.80% |
| 2010-12-31 | $155.38 Million | -- |